QuiVad

Home / Sweden / BioArctic AB

BioArctic AB

Short position disclosed on July 6, 2026.

Follow

Evolution of the disclosed total

0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 3.42% on December 16, 2024. The shaded band is the year shown above.

September 3, 2018 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Connor Clark & Lunn Investment Management Ltd.0.59%+0.09 ptJuly 6, 2026

On the other side: the funds that hold BioArctic AB Titelia

History of disclosures

201 disclosures on record for this share.
DateFund% of capitalEnd of publication
March 29, 2019Millennium International Management LP1.80%still open
March 28, 2019Millennium International Management LP1.80%still open
March 25, 2019Millennium International Management LP1.70%still open
March 24, 2019Millennium International Management LP1.70%still open
March 22, 2019Millennium International Management LP1.69%still open
March 22, 2019Citadel Advisors LLC0.56%still open
March 21, 2019Millennium International Management LP1.69%still open
March 21, 2019Citadel Advisors LLC0.56%still open
March 19, 2019Millennium International Management LP1.29%still open
March 18, 2019Millennium International Management LP1.29%still open
February 4, 2019Millennium International Management LP1.30%still open
February 3, 2019Millennium International Management LP1.30%still open
January 31, 2019Millennium International Management LP1.23%still open
January 31, 2019Marshall Wace LLP0.58%still open
January 30, 2019Millennium International Management LP1.23%still open
January 30, 2019Marshall Wace LLP0.58%still open
January 29, 2019Millennium International Management LP1.10%still open
January 28, 2019Millennium International Management LP1.10%still open
January 17, 2019Millennium International Management LP1.03%still open
January 16, 2019Millennium International Management LP1.03%still open
January 10, 2019Millennium International Management LP0.90%still open
January 9, 2019Millennium International Management LP0.90%still open
January 3, 2019Millennium International Management LP0.81%still open
January 2, 2019Millennium International Management LP0.75%still open
January 1, 2019Millennium International Management LP0.75%still open
December 14, 2018Millennium International Management LP0.60%still open
December 13, 2018Millennium International Management LP0.60%still open
December 3, 2018Marshall Wace LLP0.60%still open
December 2, 2018Marshall Wace LLP0.60%still open
November 21, 2018Marshall Wace LLP0.50%still open
November 20, 2018Marshall Wace LLP0.50%still open
November 14, 2018Millennium International Management LP0.58%still open
November 13, 2018Millennium International Management LP0.58%still open
November 13, 2018Marshall Wace LLP0.00%still open
November 12, 2018Millennium International Management LP0.66%still open
November 11, 2018Millennium International Management LP0.66%still open
October 30, 2018Marshall Wace LLP0.57%still open
October 29, 2018Marshall Wace LLP0.62%still open
October 28, 2018Marshall Wace LLP0.62%still open
October 26, 2018Millennium International Management LP0.74%still open
October 25, 2018Marshall Wace LLP0.70%still open
October 25, 2018Millennium International Management LP0.68%still open
October 24, 2018Marshall Wace LLP0.70%still open
October 24, 2018Millennium International Management LP0.68%still open
October 9, 2018Marshall Wace LLP0.69%still open
October 8, 2018Marshall Wace LLP0.70%still open
October 7, 2018Marshall Wace LLP0.70%still open
September 7, 2018Marshall Wace LLP0.60%still open
September 6, 2018Marshall Wace LLP0.60%still open
September 4, 2018Marshall Wace LLP0.52%still open

Other companies sold short in Sweden

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, BioArctic AB, source Finansinspektionen, data as at July 6, 2026, https://www.quivad.com/action/bioarctic-ab?page=4